Manufacturers Life Insurance Trims Investment Stakes Across Five Major Publicly Traded Companies

BlackRock acquired a new Franco-Nevada stake worth approximately $52.8 million during the second quarter, while Markel Group increased its position by 9.2% to 773,500 shares.
Analysts issued mixed views on Franco-Nevada: Weiss Ratings reiterated a “buy (b-)” rating, while Scotiabank lowered its price target from $290 to $274 and maintained a “sector perform” rating.
Marvell Technology CFO Daniel Durn sold 2,250 shares at an average price of $281.01, generating proceeds of about $632,273; the transaction reduced his position by 24.58%.
Amgen announced a quarterly dividend scheduled for payment on Sept. 11 to shareholders of record on Aug. 21, providing an additional shareholder-return detail beyond the institutional ownership changes.
Manufacturers Life Insurance Company trimmed its stakes across five major holdings during the second quarter, according to SEC filings. The company cut positions in Franco-Nevada by 25.3%, Marvell Technology by 31.5%, and Amgen by 8.5%, while also reducing holdings in ConocoPhillips and Applied Materials by smaller margins. The remaining stakes were valued at approximately $189 million, $153 million, $394 million, $658 million, and $417 million respectively.
The institutional rebalancing signals profit-taking in high-valuation technology stocks while other major investors moved in opposite directions. BlackRock acquired a new Franco-Nevada stake worth $52.8 million, and Markel Group increased its position by 9.2%, suggesting divergent views on precious metals exposure among institutional players.
Manufacturers Life's most aggressive exit involved semiconductor stocks. Marvell Technology saw the largest reduction at 31.5%, leaving the insurer with roughly $394 million remaining. Applied Materials was trimmed by just 1.3%, suggesting a more selective approach to semiconductor equipment makers. These cuts align with broader profit-taking in high-growth technology after a strong market run.
Franco-Nevada saw the most dramatic institutional repositioning. Manufacturers Life dumped 25.3% of its position, but BlackRock immediately stepped in with a $52.8 million new stake. Markel Group boosted its holding by 9.2% to 773,500 shares. These competing moves reflect split views on the precious metals streaming company's future.
Analyst coverage remains mixed. Weiss Ratings reiterated a "buy" rating, citing solid cash flows from precious metal streaming. But Scotiabank lowered its price target from $290 to $274 and kept a "sector perform" rating, citing updated commodity assumptions.
Amgen took an 8.5% cut, leaving Manufacturers Life with $417 million in the biotech giant. ConocoPhillips received the gentlest trim at 1.3%, with the remaining $189 million position intact. These modest reductions suggest confidence in mature, dividend-paying companies even as the insurer rotates away from higher-growth plays.
Amgen announced a quarterly dividend scheduled for payment on September 11 to shareholders of record on August 21, offering steady income to long-term holders. The company maintains robust institutional backing despite the Manufacturers Life reduction.
Marvell Technology's new CFO Daniel Durn sold 2,250 shares on June 23 at an average price of $281.01 per share, generating $632,273 in proceeds. The transaction reduced his direct stake by 24.58%, leaving him with 6,902 shares. Financial analysts note such sales often follow routine executive onboarding or pre-planned tax strategies rather than signaling distress.
Publishers
28
Articles
30
Reach
58